CGCamelia Ana Grigore

Camelia Ana Grigore

*This is an algorithmically generated author record based on publicly available information.

Camelia Ana Grigore has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • OCULAR AND ORAL MANIFESTATIONS OF PRIMARY SJÖGREN’S SYNDROME: AN INTERDISCIPLINARY PERSPECTIVE

    by Sabrina-Elena Benchea-Indrei, Anamaria Zaharescu, Camelia Ana Grigore, Gabriel Valeriu Popa, Sara Earar, Ciprian Adrian Dinu

    Primary Sjögren’s syndrome (pSS) is a chronic autoimmune disease characterized by exocrine gland dysfunction, particularly affecting the salivary and lacrimal glands. Clinically, this results in xerostomia and keratoconjunctivitis sicca, two hallmark symptoms that significantly impair patients’ quality of life. Beyond dryness, pSS encompasses a wide spectrum of oro-ocular manifestations, including mucosal atrophy, dental caries, candidiasis, and ocular surface inflammation. These symptoms reflect the shared pathophysiological mechanisms of glandular epithelial injury and immune-mediated inflammation. Accurate diagnosis requires a multidisciplinary approach, combining clinical observation with objective tests such as salivary flow measurement, ocular surface staining, and labial gland biopsy. Recent research has identified promising biomarkers, such as cathepsin S, SIGLEC1, and interferon signatures, which may improve early detection and guide personalized therapy. Integrated evaluation by dental, ophthalmological, and rheumatological specialists enhances diagnostic accuracy and facilitates individualized treatment strategies. This review provides a comprehensive overview of the oral and ocular involvement in pSS, highlighting clinical correlations, diagnostic tools, and emerging molecular insights. By addressing pSS from an interdisciplinary angle, we aim to support earlier diagnosis and better management of this underrecognized yet impactful autoimmune condition.

  • DRUG INTERACTIONS BETWEEN ANTICOAGULANT THERAPY AND INVASIVE DENTAL PROCEDURES

    by Sara Earar, Camelia Ana Grigore, Gabriel Valeriu Popa, Alina-Ramona Dimofte, Razvan Leata, Norina Consuela Forna, Doriana Agop Forna, Kamel Earar

    The management of anticoagulated patients in dentistry presents a significant challenge, requiring a balance between hemorrhagic and thromboembolic risks. Anticoagulants, including vitamin K antagonists (VKAs), direct oral anticoagulants (DOACs), and low-molecular-weight heparins (LMWHs), increase bleeding risk during invasive dental procedures. Recent guidelines emphasize that maintaining anticoagulation with appropriate hemostatic measures is generally safer than treatment interruption, which may lead to thromboembolic complications. Preoperative assessment should consider the type of anticoagulant, the patient’s medical status, and the procedure's risk level. VKAs require INR monitoring, while DOACs should be scheduled at their lowest plasma concentration. Advanced hemostatic agents (collagen, oxidized cellulose, tranexamic acid) and minimally invasive surgical techniques significantly reduce postoperative bleeding. Postoperative management includes patient education on bleeding control, avoiding NSAIDs, and close monitoring. Future research aims to develop predictable anticoagulants, advanced biomaterials, and AI-based risk assessment tools to improve patient safety. A multidisciplinary approach is essential for optimal care, ensuring successful dental treatment while minimizing complications. This review provides updated insights into best practices for managing anticoagulated patients in dentistry.

  • CHRONIC ORAL INFLAMMATION AND CARDIOVASCULAR RISK

    by Cristian Gutu, Camelia Ana Grigore, Sabrina-Elena Benchea-Indrei, Dorin Ioan Cocos, Ovidiu Schipor, Amin Bazyani

    Chronic inflammatory diseases of the oral cavity, especially periodontal disease, are highly prevalent pathologies characterized by persistent inflammation of the supporting tissues of the teeth, mainly caused by bacterial colonization and local immune response. A growing body of evidence suggests a pathogenic link between periodontal disease and cardiovascular disease (CVD), which is responsible for most global mortality. This review explores the pathophysiological, immunological, and epidemiological connections between chronic oral inflammation and cardiovascular risk. Proposed mechanisms include transient bacteremia caused by dental manipulations or spontaneous gingival bleeding, dissemination of bacterial products (e.g., lipopolysaccharides), and systemic activation of the inflammatory response. These processes can lead to endothelial dysfunction, acceleration of atherogenesis, and instability of atherosclerotic plaques. Systemic inflammatory markers, such as C-reactive protein (CRP), interleukins, and TNF-α, are often elevated in patients with severe periodontitis, correlating with an increased cardiovascular risk. Epidemiological data support the association between periodontitis and pathologies such as acute myocardial infarction, stroke, and ischemic coronary artery disease. Although the direct causal relationship remains partially elucidated, the importance of evaluating and treating chronic oral inflammation in the context of cardiovascular prevention is becoming increasingly evident. Integrating dentistry into cardiovascular risk assessment could be an important step in preventive medicine, and future research should aim at developing common biomarkers and interdisciplinary therapeutic strategies.